Literature DB >> 10189305

1997 AAP guidelines for prevention of early-onset group B streptococcal disease.

C J Baker, N A Halsey, A Schuchat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10189305     DOI： 10.1542/peds.103.3.701

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  3 in total

1.  Three new macrolide efflux (mef) gene variants in Streptococcus agalactiae.

Authors:  Yongwei Cai; Fanrong Kong; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

2.  Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.

Authors:  Q Cheng; B Carlson; S Pillai; R Eby; L Edwards; S B Olmsted; P Cleary
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.

Authors:  Qi Cheng; Steven Debol; Hong Lam; Ron Eby; Lorri Edwards; Yury Matsuka; Stephen B Olmsted; P Patrick Cleary
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.